体外膜氧合作为室间隔缺损修补术后室间隔血肿的新型管理策略
本文回顾性分析了12例室间隔缺损修补术后并发室间隔血肿(IVSH)的患者,发现仅55%在术中经食管超声心动图发现。5例(42%)患者使用体外膜氧合(ECMO)管理,其中2例(40%)存活。总体死亡率为33%。ECMO可允许血肿消退,但需注意抗凝与重复影像评估。
要点
- VSD修补术后IVSH罕见,术中TEE仅发现55%,易漏诊。
- ECMO可用于IVSH管理,5例中2例存活。
- ECMO期间需平衡抗凝避免血肿扩大,并重复影像评估。
核心结论
- VSD修补术后IVSH可导致临床失代偿和死亡,可能与术中漏诊比例高有关。
- ECMO应被视为允许IVSH消退的重要管理方式,但需考虑适当抗凝以避免血肿扩大,并在ECMO期间重复影像评估室间隔。
研究设计与样本
- 回顾性队列研究,检索1980年1月至2016年12月机构数据库超声心动图报告中「血肿」一词,纳入12例IVSH患者。
- 手术时平均年龄59±41天,体重3.4(2.9-5.1)kg,最常见诊断为法洛四联症。
主要发现
- 所有患者均行术中经食管超声心动图(TEE),但仅55%(6/11,缺失1例)的IVSH在术中被发现。
- 5例未在术中发现(缺失1例)的患者,术后因心律失常/失代偿经超声心动图检测到IVSH,时间为术后10.1±7.9小时。
- 5例(42%)患者使用ECMO管理(1例无法脱离体外循环),其中2例(40%)存活。
- 总体死亡率为33%。
- 所有存活者IVSH消退的平均时间为20±185天。
临床怎么用
- VSD修补术后应警惕IVSH,尤其当出现心律失常或血流动力学失代偿时,需及时行超声心动图检查。
- 对于IVSH导致临床失代偿的患者,可考虑使用ECMO支持,同时注意抗凝管理以避免血肿扩大,并重复影像评估。
局限性
- 回顾性研究,样本量小(N=12),存在数据缺失(如术中TEE发现率分析中缺失1例)。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Interventricular septal hematoma (IVSH) is a rare complication, which may result from ventricular septal defect (VSD) repair. IVSH can result in conduction and/or hemodynamic abnormalities related to impaired ventricular filling or outflow tract obstruction. We report the novel use of extracorporeal membrane oxygenation (ECMO) for management. METHODS: Echocardiography reports (January 1980 to December 2016) were searched for the term "hematoma" in our institutional database and reviewed to determine appropriate cases. Charts and imaging (reports) data were abstracted. All intraoperative and select postoperative echocardiograms were reread by a pediatric cardiologist. RESULTS: N = 12 patients with IVSH. Mean age and weight at surgery were 59 ± 41 days and 3.4 (2.9-5.1) kg, respectively, while the most frequent diagnosis was tetralogy of Fallot. Although all patients had intraoperative transesophageal echocardiography (TEE), only 55% (6 of 11, missing [m] = 1) of IVSH were discovered intraoperatively. Of the 5 patients not discovered intraoperatively (m = 1), IVSH was postoperatively detected secondary to arrhythmia/decompensation by echocardiogram 10.1 ± 7.9 hours postoperatively. Five patients (42%) were managed with ECMO (1 unable to separate from bypass). Overall mortality was 33%. For patients in whom ECMO was used, 2 of 5 (40%) survived. Mean time to IVSH resolution in all survivors was 20 ± 185 days. CONCLUSIONS: IVSH from VSD repair can result in clinical decompensation and mortality. This may relate to the high proportion missed intraoperatively. ECMO should be considered an important modality, which can allow for IVSH resolution. However, considerations must be made to allow for appropriate anticoagulation to avoid hematoma expansion and repeat imaging during ECMO to continually assess the interventricular septum.
引用
- Jegatheeswaran A, Cohen MS, Gaynor JW, et al. Extracorporeal membrane oxygenation as a novel management strategy for interventricular septal hematoma following ventricular septal defect repair. J Thorac Cardiovasc Surg. 2019. PMID: 31810644. doi:10.1016/j.jtcvs.2019.09.150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。